+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Cannabis Market: Products, Technologies, and Applications

  • PDF Icon

    Report

  • 131 Pages
  • January 2026
  • Region: Global
  • BCC Research
  • ID: 6219824
The global market for cannabis was valued at from $45.6 billion in 2025 and is projected to reach $79.3 billion by the end of 2030, at a compound annual growth rate (CAGR) of 11.7% during the forecast period of 2025 to 2030.

Cannabis exhibits psychoactive effects due to its tetrahydrocannabinol (THC) content. The plant contains over 500 chemical compounds, including more than 100 cannabinoids. Among these, THC is the principal psychoactive compound, responsible for the characteristic “high,” while cannabidiol (CBD) is the main nonpsychoactive cannabinoid, widely recognized for its potential therapeutic benefits.

The competitive landscape of the legal retail cannabis industry is diverse and highly fragmented. Leading cannabis companies include Curaleaf, Trulieve, Green Thumb Industries, Verano, Cresco Labs and Tilray Brands Inc.

Report Scope

This report is a current and important business tool for evaluating technologies, trends, products, and market participants in the cannabis sector. The report identifies key industries in the global cannabis market, including cannabis analytical testing equipment and services, cannabis extraction equipment and services, legal cannabis retail sales (medicinal and adult use only), and cannabis-derived pharmaceuticals. BCC Research estimates market data for 2024 (the base year) and 2025 and forecast values through 2030.

Illegal cannabis, industrial hemp, and cannabis cultivated for personal use are excluded from the report. It is important to note that retail sales figures only include domestic medical and adult-use cannabis sales, excluding the export market.

The report includes:

  • 12 data tables and 77 additional tables
  • In-depth analysis of the global oligonucleotides market
  • Analyses of the global market trends, with historic revenue (sales data) from 2022 to 2024, estimates for 2025 and projections of CAGRs through 2030
  • Estimates of the current market size and revenue prospects for the global oligonucleotide synthesis market, accompanied by a market share analysis by product, application and region
  • Facts and figures pertaining to the global market dynamics, opportunities and deterrents, technological advancements, regulations, prospects and the impact of macroeconomic factors
  • Insights derived from Porter’s Five Forces model, as well as global supply chain analyses
  • Patent review, featuring key granted and published patents
  • Analysis of the industry structure, including companies’ market shares and rankings, product mappings, strategic initiatives, M&A activity and a venture funding outlook
  • Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, as well as the ESG risk ratings and practices of leading companies
  • Company profiles of major players within the industry, including Curaleaf, Trulieve, Green Thumb Industries, Verano, Cresco Labs, Tilray Brands Inc

Table of Contents

Chapter 1 Executive Summary
  • Market Outlook
  • Scope of Report
  • Market Summary
  • Market Dynamics
  • Emerging Trends
  • Analysis by Segment
  • Analysis by Region
  • Conclusion
Chapter 2 Market Overview
  • Cannabis Definition
  • Physiological Effects of Cannabinoid Compounds
  • Categories of Cannabis Products
  • Cannabis: Addiction and Other Negative Side Effects
  • Analysis of Macroeconomic Factors
  • Economic Growth and Income Levels
  • Capital Markets and Interest Rates
  • Employment and Wage Trends
  • Consumer Health and Wellness Trends
  • Impact of U.S. Tariffs
  • Porter's Five Forces Analysis
  • Bargaining Power of Buyers: High
  • Bargaining Power of Suppliers: Low to Moderate
  • Potential for New Entrants to the Market: Moderate
  • Threat of Substitutes: High
  • Competition in the Industry: High
Chapter 3 Market Dynamics
  • Market Dynamics
  • Market Drivers
  • Regulatory Expansion and Legalization
  • Expansion of Telemedicine
  • Rising Demand for Higher Potency Products
  • Product Innovations and Industry Investments
  • Market Challenges
  • Plunging Prices Driven by Cannabis Oversupply
  • Regulatory Uncertainties and Fragmentation
  • Funding Challenge
  • Supply Chain and Quality Challenges
  • Illicit Market
  • Market Trends
  • Shift Toward Premiumization and Product Differentiation
  • Industry Consolidation and Financial Restructuring
  • Increasing Demand for Expanded Cannabis Research
Chapter 4 Regulatory Landscape
  • Overview
  • U.S.
  • Canada
  • U.K.
  • Germany
  • Italy
  • Australia
  • Others
Chapter 5 Emerging Technologies and Developments
  • Emerging Technologies and Developments
  • Genetic Optimization and Breeding in Cannabis
  • Focus on Purity, Full Spectrum and Terpene Preservation in Cannabis Extraction
  • Clinical Trial Analysis
  • By Condition Type
  • By Phase Type
  • By Funder Type
Chapter 6 Market Segmentation Analysis
  • Segmentation Breakdown
  • Global Cannabis Market
  • Cannabis Analytical Testing: Services and Equipment
  • Core Regulatory Compliance Testing Panel
  • Cannabis Analytical Testing Services Market
  • Cannabis Analytical Testing Equipment Market
  • Cannabis Extraction: Equipment and Services
  • CO2 Extraction
  • Ethanol Extraction
  • Hydrocarbon Extraction
  • Solvent-free Extractions
  • Cannabis Extraction Equipment Market
  • Cannabis Extraction Services Market
  • Cannabis Retail Sales
  • Medical Cannabis
  • Adult-Use Cannabis
  • North America Retail Sales Market
  • European Retail Sales Market
  • Rest of the World Retail Sales Market
  • Cannabis-Derived Pharmaceuticals
  • Synthetic Cannabis Drugs
  • Cannabis-Derived Drug Product
Chapter 7 Competitive Intelligence
  • Cannabis Retail Sales
  • Key Takeaways
  • Market Share Analysis
  • Cannabis Analytical Testing: Equipment and Services
  • Cannabis Extraction: Equipment and Services
  • Cannabis-Derived Pharmaceuticals
Chapter 8 Sustainability in Cannabis Market: An ESG Perspective
  • Introduction to ESG
  • Key ESG Issues Specific to Cannabis Market
  • High Energy Intensity and Carbon Footprint of Indoor Cultivation
  • High Water Consumption
  • Pesticide and Chemical Use
  • Social Impact of Cannabis Use
  • Labor Practices and Employee Rights
  • Ethical Marketing
  • Concluding Remarks
Chapter 9 Appendix
  • Methodology
  • Sources
  • Abbreviations
  • Company Profiles
  • AURORA CANNABIS INC.
  • C3 INDUSTRIES
  • CANOPY GROWTH CORP.
  • CRESCO LABS
  • CURALEAF
  • DEMECAN
  • GLASS HOUSE BRANDS INC.
  • GREEN THUMB INDUSTRIES (GTI)
  • MEDIPHARM LABS
  • PHARMACANN INC.
  • SNDL INC.
  • TERRASCEND
  • TILRAY BRANDS INC.
  • TRULIEVE
  • VERANO
  • Emerging Start-ups/Market Disruptors
List of Tables
Summary Table: Global Market for Cannabis, by Region, Through 2030
Table 1: Physiological Effects of Tetrahydrocannabinol and Cannabidiol
Table 2: Differences Between Marijuana, Hemp and Hemp Seeds/Oil
Table 3: Cannabis Legalization Status Across U.S. States and the Federal District, 2025
Table 4: Legality of Cannabis Use in Different Countries for Recreational and Medical Purposes
Table 5: Companies Developing Cannabis-based Drugs/Formulations
Table 6: Global Market for Cannabis, by Type, Through 2030
Table 7: Global Market for Cannabis Analytical Testing Equipment and Services, by Type, Through 2030
Table 8: Global Market for Cannabis Analytical Testing Services, by Region, Through 2030
Table 9: Companies Providing Analytical Testing Equipment to the Cannabis Market
Table 10: Global Market for Cannabis Analytical Testing Equipment, by Region, Through 2030
Table 11: Advantages and Disadvantages of Major Cannabis Extraction Methods
Table 12: Examples of Companies Providing Extraction Equipment to the Cannabis Market
Table 13: Cannabis Extraction Equipment Cost Comparison
Table 14: Companies Providing Extraction Services to the Cannabis Market
Table 15: Global Market for Cannabis Extraction Equipment and Services, by Region, Through 2030
Table 16: Global Market for Cannabis Retail Sales, by Application, Through 2030
Table 17: Countries with Legalized Medical Cannabis, 2025
Table 18: Key Medical Cannabis Markets
Table 19: Countries that Fully or Partially Legalized Recreational Cannabis
Table 20: Global Market for Cannabis Retail Sales, by Region, Through 2030
Table 21: North American Market for Cannabis Retail Sales, by Country, Through 2030
Table 22: U.S. States with Over $1 Billion in Cannabis Sales, 2024
Table 23: European Market for Cannabis Retail Sales, by Country, Through 2030
Table 24: Cannabis Legal Status in Selected European Countries, 2025
Table 25: RoW Market for Cannabis Retail Sales, by Country, Through 2030
Table 26: Cannabis-Derived and Cannabinoid-Based Drugs: U.S. and Global Approvals
Table 27: Global Market for Cannabis-Derived Pharmaceuticals, by Region, Through 2030
Table 28: Global Market Shares for Cannabis Retail Sales, by Company, 2024
Table 29: Information Sources for this Report
Table 30: Abbreviations Used in This Report
Table 31: Aurora Cannabis Inc.: Company Snapshot
Table 32: Aurora Cannabis Inc.: Financial Performance, FY 2023 and 2024
Table 33: Aurora Cannabis Inc.: Product Portfolio
Table 34: Aurora Cannabis Inc.: News/Key Developments, 2025
Table 35: C3 Industries: Company Snapshot
Table 36: C3 Industries: Product Portfolio
Table 37: C3 Industries: News/Key Developments, 2024
Table 38: Canopy Growth Corp.: Company Snapshot
Table 39: Canopy Growth Corp.: Financial Performance, FY 2023 and 2024
Table 40: Canopy Growth Corp.: Product Portfolio
Table 41: Canopy Growth Corp.: News/Key Developments, 2024-2025
Table 42: Cresco Labs: Company Snapshot
Table 43: Cresco Labs: Financial Performance, FY 2023 and 2024
Table 44: Cresco Labs: Product Portfolio
Table 45: Cresco Labs: News/Key Developments, 2024-2025
Table 46: Curaleaf: Company Snapshot
Table 47: Curaleaf: Financial Performance, FY 2023 and 2024
Table 48: Curaleaf: Product Portfolio
Table 49: Curaleaf: News/Key Developments, 2024
Table 50: Demecan: Company Snapshot
Table 51: Demecan: Product Portfolio
Table 52: Demecan: News/Key Developments, 2024-2025
Table 53: Glass House Brands Inc.: Company Snapshot
Table 54: Glass House Brands Inc.: Financial Performance, FY 2023 and 2024
Table 55: Glass House Brands Inc.: Product Portfolio
Table 56: Glass House Brands Inc.: News/Key Developments, 2025
Table 57: Green Thumb Industries: Company Snapshot
Table 58: Green Thumb Industries: Financial Performance, FY 2023 and 2024($ Millions)
Table 59: Green Thumb Industries: Product Portfolio
Table 60: Green Thumb Industries: News/Key Developments, 2024-2025
Table 61: MediPharm Labs: Company Snapshot
Table 62: MediPharm Labs: Financial Performance, FY 2023 and 2024
Table 63: MediPharm Labs: Product Portfolio
Table 64: MediPharm Labs: News/Key Developments, 2024-2025
Table 65: PharmaCann Inc.: Company Snapshot
Table 66: PharmaCann Inc.: Product Portfolio
Table 67: PharmaCann Inc.: News/Key Developments, 2024-2025
Table 68: SNDL Inc.: Company Snapshot
Table 69: SNDL Inc.: Financial Performance, FY 2023 and 2024
Table 70: SNDL Inc.: Product Portfolio
Table 71: SNDL Inc.: News/Key Developments, 2024
Table 72: TerrAscend: Company Snapshot
Table 73: TerrAscend: Financial Performance, FY 2023 and 2024
Table 74: TerrAscend: Product Portfolio
Table 75: TerrAscend: News/Key Developments, 2025
Table 76: Tilray Brands Inc.: Company Snapshot
Table 77: Tilray Brands Inc.: Financial Performance, FY 2023 and 2024
Table 78: Tilray Brands Inc.: Product Portfolio
Table 79: Tilray Brands Inc.: News/Key Developments, 2024-2025
Table 80: Trulieve: Company Snapshot
Table 81: Trulieve: Financial Performance, FY 2023 and 2024
Table 82: Trulieve: Product Portfolio
Table 83: Trulieve: News/Key Developments, 2025
Table 84: Verano: Company Snapshot
Table 85: Verano: Financial Performance, FY 2023 and 2024
Table 86: Verano: Product Portfolio
Table 87: Verano: News/Key Developments, 2024-2025
Table 88: List of a Few Emerging Startups/Market Disruptors
List of Figures
Summary Figure: Global Market Shares for Cannabis, by Region, 2024
Figure 1: Porter’s Five Forces Analysis: Global Cannabis Market
Figure 2: Market Dynamics of Cannabis
Figure 3: Clinical Trials of Cannabis, by Condition, as of December 2025
Figure 4: Shares of Active Clinical Trials for Cannabis, by Phase, as of December 2025
Figure 5: Shares for Clinical Trials of Cannabis, by Funder Type, as of December 2025
Figure 6: Global Market Shares for Cannabis, by Type, 2024
Figure 7: Global Market Shares for Cannabis Analytical Testing Equipment and Services, by Type, 2024
Figure 8: Global Market Shares for Cannabis Analytical Testing Services, by Region, 2024
Figure 9: Global Market Shares for Cannabis Analytical Testing Equipment, by Region, 2024
Figure 10: Global Market Shares for Cannabis Extraction Equipment and Services, by Region, 2024
Figure 11: Global Market Shares for Cannabis Retail Sales, by Application, 2024
Figure 12: Global Market Shares for Cannabis Retail Sales, by Region, 2024
Figure 13: North American Market Shares for Cannabis Retail Sales, by Country, 2024
Figure 14: European Market Shares for Cannabis Retail Sales, by Country, 2024
Figure 15: RoW Market Shares for Cannabis Retail Sales, by Country, 2024
Figure 16: Global Market Shares for Cannabis-Derived Pharmaceuticals, by Region, 2024
Figure 17: Aurora Cannabis Inc.: Revenue Shares, by Business Unit, FY 2024
Figure 18: Aurora Cannabis Inc.: Revenue Shares, by Country/Region, FY 2024
Figure 19: Canopy Growth Corp.: Revenue Shares, by Business Unit, FY 2024
Figure 20: Canopy Growth Corp.: Revenue Shares, by Country/Region, FY 2024
Figure 21: Cresco Labs: Revenue Shares, by Business Unit, FY 2024
Figure 22: Cresco Labs: Revenue Shares, by Country/Region, FY 2024
Figure 23: Curaleaf: Revenue Shares, by Business Unit, FY 2024
Figure 24: Curaleaf: Revenue Shares, by Country/Region, FY 2024
Figure 25: Glass House Brands Inc.: Revenue Shares, by Business Unit, FY 2024
Figure 26: Glass House Brands Inc.: Revenue Shares, by Country/Region, FY 2024
Figure 27: Green Thumb Industries (GTI): Revenue Shares, by Business Unit, FY 2024
Figure 28: Green Thumb Industries (GTI): Revenue Shares, by Country/Region, FY 2024
Figure 29: MediPharm Labs: Revenue Shares, by Business Unit, FY 2024
Figure 30: MediPharm Labs: Revenue Shares, by Country/Region, FY 2024
Figure 31: SNDL Inc.: Revenue Shares, by Business Unit, FY 2024
Figure 32: TerrAscend: Revenue Shares, by Business Unit, FY 2024
Figure 33: Tilray Brands Inc.: Revenue Shares, by Business Unit, FY 2024
Figure 34: Tilray Brands Inc.: Revenue Shares, by Country/Region, FY 2024
Figure 35: Trulieve: Revenue Shares, by Business Unit, FY 2024
Figure 36: Trulieve: Revenue Shares, by Country/Region, FY 2024
Figure 37: Verano: Revenue Shares, by Business Unit, FY 2024
Figure 38: Verano: Revenue Shares, by Country/Region, FY 2024

Companies Mentioned

  • Aurora Cannabis Inc.
  • C3 Industries
  • Canopy Growth Corp.
  • Cresco Labs
  • Curaleaf
  • Demecan
  • Glass House Brands Inc.
  • Green Thumb Industries (Gti)
  • Medipharm Labs
  • Pharmacann Inc.
  • Sndl Inc.
  • Terrascend
  • Tilray Brands Inc.
  • Trulieve
  • Verano

Table Information